Osteoarthritis
Conditions
Keywords
Total Hip Arthroplasty THA
Brief summary
The primary purpose of this study is to demonstrate the POLARSTEM™ Ti/HA cumulative femoral stem revision rate at 10 years. The secondary purpose of this study is to provide 10 years of safety and effectiveness data of POLARSTEM™ Ti/HA in terms of radiographic and clinical performance
Detailed description
This is a multicenter retrospective longterm clinical outcome study conducted in up to 6 hospitals in France. 502 subjects who have undergone THA with POLARSTEM™ from 2002 to 2005 will be enrolled in this study and clinical and radiographically followed up for at least 10 years. Subjects who have not reached the 10-year post surgery timepoint will be invited to a 10-year post-operative follow-up visit to obtain the clinical and radiographic outcome measures.
Interventions
Patients who had a primary THA between 2002 and 2005
Sponsors
Study design
Eligibility
Inclusion criteria
1. Subject required and received primary total hip arthroplasty between 2002 and 2005. 2. Subject received the POLARSTEM™ Ti/HA unilateral or bilateral, due to severe hip joint damage resulting from arthrosis, degenerative disease, traumatic events, inflammatory or rheumatoid processes. 3. Subject received the non-cemented POLARSYSTEM (POLARSTEM™ Ti/HA in combination with POLARCUP™). 4. Subject was aged between 18 and 75 at time of surgery. 5. Signed Informed Consent (ICF).
Exclusion criteria
1. Subject received the cemented POLARSTEM™. 2. Previously failed endoprosthesis and/or THR components in relevant hip. 3. Medical or mental health conditions which could impair the stubject's ability or willingness to comply with the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Femoral stem revision rate at 10 years for any reason | since surgery until 10 years Follow Up | Long term cumulative femoral stem revision rate of Polarstem will be evaluated in 502 subjects |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of subjects with revision of any components for any reason | date of surgery until 10 years Follow Up | Long-term cumulative revision rate of the cup will be evaluated in 502 subjects |
| Standard radiographic assessment at least at 10 years | date of surgery and at 10 years Follow Up | radiographic evaluation on x-rays to assess the osseointegration and orientation of cup and stem, heterotopic ossification, signs of radiolucent lines, osteolysis, atrophy and hypertrophy |
| Hip Disability and Osteoarthritis Outcome Score (HOOS) at least at 10-year assessment as patient reported outcome (PRO | at 10 years Follow Up | — |
| Merle D'Aubigné and Postel (MAP) at least at 10-year assessment | pre-operative and at 10 years Follow Up | — |
| Adverse Events | through study completion, an average of 10 years | — |
Countries
France